These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9526736)

  • 21. Functional p53 status as a biomarker for chemotherapy response in oral-cavity cancer.
    Mroz EA; Rocco JW
    J Clin Oncol; 2010 Feb; 28(5):715-7. PubMed ID: 20048171
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide.
    Colozza M; Mosconi AM; Gori S; Belsanti V; Basurto C; De Angelis V; Giansanti M; Tonato M
    Am J Clin Oncol; 1997 Oct; 20(5):522-6. PubMed ID: 9345342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [p53 mutations and chemoresistance in oromaxillofacial squamous-cell carcinomas. The results of a molecular genetics study of p53 in metastatic oromaxillofacial tumors and an evaluation of the response to neoadjuvant chemotherapeutic treatment].
    Cutilli T; Papola F; Di Emidio P; Leocata P; Corbacelli A
    Minerva Stomatol; 1998; 47(1-2):1-9. PubMed ID: 9578641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Local chemotherapy for squamous cell cancer of the oral cavity and oropharynx].
    Rohde S; Kovács AF; Zanella FE; Berkefeld J; Turowski B
    Radiologe; 2005 Sep; 45(9):843-50. PubMed ID: 16021409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
    Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
    Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
    Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
    Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of preoperative radiation and chemotherapy on AgNOR counts in oral squamous cell carcinoma.
    Kinoshita Y; Dohi M; Mizutani N; Ikeda A
    J Oral Maxillofac Surg; 1996 Mar; 54(3):304-7; discussion 307-8. PubMed ID: 8600237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
    Abbasi MM; Khiavi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban-Esfahlan R
    Asian Pac J Cancer Prev; 2014; 15(19):8377-82. PubMed ID: 25339032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
    Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
    Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of regionally metastatic pure squamous cell carcinoma of the urinary bladder successfully treated with radical chemoradiotherapy].
    Inui M; Fujita K; Ueda N; Takenaka I; Kakehi Y
    Hinyokika Kiyo; 2002 Jan; 48(1):33-5. PubMed ID: 11868383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of neo-adjuvant chemotherapy for oral squamous cell carcinoma].
    Kurokawa H; Miura K; Yamashita Y; Tokudome S; Murata T; Kajiyama M
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1273-8. PubMed ID: 9279346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induction therapy of locally-advanced nasophayngeal cancer].
    Bolotina LV; Kornietskaia AL
    Vopr Onkol; 2011; 57(2):225-31. PubMed ID: 21809670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
    Ikushima I; Korogi Y; Ishii A; Hirai T; Yamura M; Nishimura R; Baba Y; Yamashita Y; Shinohara M
    Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
    Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy.
    Vargas-Roig LM; Gago FE; Tello O; Aznar JC; Ciocca DR
    Int J Cancer; 1998 Oct; 79(5):468-75. PubMed ID: 9761114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved survival with preoperative chemotherapy followed by resection uncompromised by tumor response for advanced squamous cell carcinoma of the head and neck.
    Loré JM; Diaz-Ordaz E; Spaulding M; Chary K; Kaufman S; Lawrence W; Hong F; Gerold T; Sundquist N; Barrali RA
    Am J Surg; 1995 Nov; 170(5):506-11. PubMed ID: 7485744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
    Ikegawa S; Saida T; Obayashi H; Sasaki A; Esumi H; Ikeda S; Kiyohara Y; Hayasaka K; Ishihara K
    J Dermatol; 1989 Jun; 16(3):227-30. PubMed ID: 2551943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of nonresectable esophageal cancer treated by the combination of cisplatin, 5-fluorouracil and THP-adriamycin].
    Anai H; Toda T; Ichiyoshi Y; Miura O; Matsuzaki K; Minamisono Y; Nagasaki S
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1241-4. PubMed ID: 8333752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.